世界の経皮スコポラミン市場:販売動向2018

【英語タイトル】Global Transdermal Scopolamine Sales Market Report 2018

QYResearchが出版した調査資料(QYR8021843)・商品コード:QYR8021843
・発行会社(調査会社):QYResearch
・発行日:2017年12月29日
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、経皮スコポラミンの世界市場について調査・分析し、経皮スコポラミンのメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、経皮スコポラミン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・経皮スコポラミン市場概要
・経皮スコポラミンのメーカー別販売量・メーカー別シェア
・経皮スコポラミンの世界市場:種類別販売量・市場シェア
・経皮スコポラミンの世界市場:用途別販売量・市場シェア
・経皮スコポラミンの世界市場:地域別販売量・市場シェア
・経皮スコポラミンのアメリカ市場規模
・経皮スコポラミンの中国市場規模
・経皮スコポラミンのヨーロッパ市場規模
・経皮スコポラミンの日本市場規模
・経皮スコポラミンの東南アジア市場規模
・経皮スコポラミンのインド市場規模
・経皮スコポラミンのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・経皮スコポラミンのコスト分析・価格動向
・経皮スコポラミンの産業チェーン(サプライチェーン分析)
・経皮スコポラミンのマーケティング戦略・販売チャネル、流通業者
・経皮スコポラミン市場への影響要因分析
・経皮スコポラミンの世界市場予測
・経皮スコポラミンのアメリカ市場予測
・経皮スコポラミンの中国市場予測
・経皮スコポラミンのヨーロッパ市場予測
・経皮スコポラミンの日本市場予測
・経皮スコポラミンの東南アジア市場予測
・経皮スコポラミンのインド市場予測
・経皮スコポラミンの種類別世界市場予測
・経皮スコポラミンの用途別世界市場予測
...
【レポートの概要】

In this report, the global Transdermal Scopolamine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Transdermal Scopolamine for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Transdermal Scopolamine market competition by top manufacturers/players, with Transdermal Scopolamine sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Baxter International Inc.
GlaxoSmithKline plc
Novartis AG
Perrigo Company plc.
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Ambulance Center
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Transdermal Scopolamine Sales Market Report 2017
1 Transdermal Scopolamine Market Overview
1.1 Product Overview and Scope of Transdermal Scopolamine
1.2 Classification of Transdermal Scopolamine by Product Category
1.2.1 Global Transdermal Scopolamine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Transdermal Scopolamine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Tablet Type
1.2.4 Syrups Type
1.2.5 Injections Type
1.2.6 Patch Type
1.2.7 Gel Type
1.3 Global Transdermal Scopolamine Market by Application/End Users
1.3.1 Global Transdermal Scopolamine Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Ambulance Center
1.3.5 Others
1.4 Global Transdermal Scopolamine Market by Region
1.4.1 Global Transdermal Scopolamine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Transdermal Scopolamine Status and Prospect (2012-2022)
1.4.3 China Transdermal Scopolamine Status and Prospect (2012-2022)
1.4.4 Europe Transdermal Scopolamine Status and Prospect (2012-2022)
1.4.5 Japan Transdermal Scopolamine Status and Prospect (2012-2022)
1.4.6 Southeast Asia Transdermal Scopolamine Status and Prospect (2012-2022)
1.4.7 India Transdermal Scopolamine Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Transdermal Scopolamine (2012-2022)
1.5.1 Global Transdermal Scopolamine Sales and Growth Rate (2012-2022)
1.5.2 Global Transdermal Scopolamine Revenue and Growth Rate (2012-2022)

2 Global Transdermal Scopolamine Competition by Players/Suppliers, Type and Application
2.1 Global Transdermal Scopolamine Market Competition by Players/Suppliers
2.1.1 Global Transdermal Scopolamine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Transdermal Scopolamine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Transdermal Scopolamine (Volume and Value) by Type
2.2.1 Global Transdermal Scopolamine Sales and Market Share by Type (2012-2017)
2.2.2 Global Transdermal Scopolamine Revenue and Market Share by Type (2012-2017)
2.3 Global Transdermal Scopolamine (Volume and Value) by Region
2.3.1 Global Transdermal Scopolamine Sales and Market Share by Region (2012-2017)
2.3.2 Global Transdermal Scopolamine Revenue and Market Share by Region (2012-2017)
2.4 Global Transdermal Scopolamine (Volume) by Application

3 United States Transdermal Scopolamine (Volume, Value and Sales Price)
3.1 United States Transdermal Scopolamine Sales and Value (2012-2017)
3.1.1 United States Transdermal Scopolamine Sales and Growth Rate (2012-2017)
3.1.2 United States Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
3.1.3 United States Transdermal Scopolamine Sales Price Trend (2012-2017)
3.2 United States Transdermal Scopolamine Sales Volume and Market Share by Players
3.3 United States Transdermal Scopolamine Sales Volume and Market Share by Type
3.4 United States Transdermal Scopolamine Sales Volume and Market Share by Application

4 China Transdermal Scopolamine (Volume, Value and Sales Price)
4.1 China Transdermal Scopolamine Sales and Value (2012-2017)
4.1.1 China Transdermal Scopolamine Sales and Growth Rate (2012-2017)
4.1.2 China Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
4.1.3 China Transdermal Scopolamine Sales Price Trend (2012-2017)
4.2 China Transdermal Scopolamine Sales Volume and Market Share by Players
4.3 China Transdermal Scopolamine Sales Volume and Market Share by Type
4.4 China Transdermal Scopolamine Sales Volume and Market Share by Application

5 Europe Transdermal Scopolamine (Volume, Value and Sales Price)
5.1 Europe Transdermal Scopolamine Sales and Value (2012-2017)
5.1.1 Europe Transdermal Scopolamine Sales and Growth Rate (2012-2017)
5.1.2 Europe Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Transdermal Scopolamine Sales Price Trend (2012-2017)
5.2 Europe Transdermal Scopolamine Sales Volume and Market Share by Players
5.3 Europe Transdermal Scopolamine Sales Volume and Market Share by Type
5.4 Europe Transdermal Scopolamine Sales Volume and Market Share by Application

6 Japan Transdermal Scopolamine (Volume, Value and Sales Price)
6.1 Japan Transdermal Scopolamine Sales and Value (2012-2017)
6.1.1 Japan Transdermal Scopolamine Sales and Growth Rate (2012-2017)
6.1.2 Japan Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Transdermal Scopolamine Sales Price Trend (2012-2017)
6.2 Japan Transdermal Scopolamine Sales Volume and Market Share by Players
6.3 Japan Transdermal Scopolamine Sales Volume and Market Share by Type
6.4 Japan Transdermal Scopolamine Sales Volume and Market Share by Application

7 Southeast Asia Transdermal Scopolamine (Volume, Value and Sales Price)
7.1 Southeast Asia Transdermal Scopolamine Sales and Value (2012-2017)
7.1.1 Southeast Asia Transdermal Scopolamine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Transdermal Scopolamine Sales Price Trend (2012-2017)
7.2 Southeast Asia Transdermal Scopolamine Sales Volume and Market Share by Players
7.3 Southeast Asia Transdermal Scopolamine Sales Volume and Market Share by Type
7.4 Southeast Asia Transdermal Scopolamine Sales Volume and Market Share by Application

8 India Transdermal Scopolamine (Volume, Value and Sales Price)
8.1 India Transdermal Scopolamine Sales and Value (2012-2017)
8.1.1 India Transdermal Scopolamine Sales and Growth Rate (2012-2017)
8.1.2 India Transdermal Scopolamine Revenue and Growth Rate (2012-2017)
8.1.3 India Transdermal Scopolamine Sales Price Trend (2012-2017)
8.2 India Transdermal Scopolamine Sales Volume and Market Share by Players
8.3 India Transdermal Scopolamine Sales Volume and Market Share by Type
8.4 India Transdermal Scopolamine Sales Volume and Market Share by Application

9 Global Transdermal Scopolamine Players/Suppliers Profiles and Sales Data
9.1 Baxter International Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Transdermal Scopolamine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Baxter International Inc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 GlaxoSmithKline plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Transdermal Scopolamine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 GlaxoSmithKline plc Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Novartis AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Transdermal Scopolamine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Perrigo Company plc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Transdermal Scopolamine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Perrigo Company plc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Caleb Pharmaceuticals, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Transdermal Scopolamine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Myungmoon Pharma Co. LTD.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Transdermal Scopolamine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview

10 Transdermal Scopolamine Maufacturing Cost Analysis
10.1 Transdermal Scopolamine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Transdermal Scopolamine
10.3 Manufacturing Process Analysis of Transdermal Scopolamine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Transdermal Scopolamine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Transdermal Scopolamine Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Transdermal Scopolamine Market Forecast (2017-2022)
14.1 Global Transdermal Scopolamine Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Transdermal Scopolamine Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Transdermal Scopolamine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Transdermal Scopolamine Price and Trend Forecast (2017-2022)
14.2 Global Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Transdermal Scopolamine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Transdermal Scopolamine Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Transdermal Scopolamine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Transdermal Scopolamine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Transdermal Scopolamine Sales Forecast by Type (2017-2022)
14.3.2 Global Transdermal Scopolamine Revenue Forecast by Type (2017-2022)
14.3.3 Global Transdermal Scopolamine Price Forecast by Type (2017-2022)
14.4 Global Transdermal Scopolamine Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Transdermal Scopolamine
Figure Global Transdermal Scopolamine Sales Volume Comparison (Units) by Type (2012-2022)
Figure Global Transdermal Scopolamine Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Type Product Picture
Figure Syrups Type Product Picture
Figure Injections Type Product Picture
Figure Patch Type Product Picture
Figure Gel Type Product Picture
Figure Global Transdermal Scopolamine Sales Comparison (Units) by Application (2012-2022)
Figure Global Sales Market Share of Transdermal Scopolamine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Ambulance Center Examples
Table Key Downstream Customer in Ambulance Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Transdermal Scopolamine Market Size (Million USD) by Regions (2012-2022)
Figure United States Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Transdermal Scopolamine Sales Volume (Units) and Growth Rate (2012-2022)
Figure Global Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Transdermal Scopolamine Sales Volume (Units) (2012-2017)
Table Global Transdermal Scopolamine Sales (Units) of Key Players/Suppliers (2012-2017)
Table Global Transdermal Scopolamine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Transdermal Scopolamine Sales Share by Players/Suppliers
Figure 2017 Transdermal Scopolamine Sales Share by Players/Suppliers
Figure Global Transdermal Scopolamine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Transdermal Scopolamine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Transdermal Scopolamine Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Transdermal Scopolamine Revenue Share by Players
Table 2017 Global Transdermal Scopolamine Revenue Share by Players
Table Global Transdermal Scopolamine Sales (Units) and Market Share by Type (2012-2017)
Table Global Transdermal Scopolamine Sales Share (Units) by Type (2012-2017)
Figure Sales Market Share of Transdermal Scopolamine by Type (2012-2017)
Figure Global Transdermal Scopolamine Sales Growth Rate by Type (2012-2017)
Table Global Transdermal Scopolamine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Transdermal Scopolamine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Type (2012-2017)
Figure Global Transdermal Scopolamine Revenue Growth Rate by Type (2012-2017)
Table Global Transdermal Scopolamine Sales Volume (Units) and Market Share by Region (2012-2017)
Table Global Transdermal Scopolamine Sales Share by Region (2012-2017)
Figure Sales Market Share of Transdermal Scopolamine by Region (2012-2017)
Figure Global Transdermal Scopolamine Sales Growth Rate by Region in 2016
Table Global Transdermal Scopolamine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Transdermal Scopolamine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Region (2012-2017)
Figure Global Transdermal Scopolamine Revenue Growth Rate by Region in 2016
Table Global Transdermal Scopolamine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Transdermal Scopolamine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Transdermal Scopolamine by Region (2012-2017)
Figure Global Transdermal Scopolamine Revenue Market Share by Region in 2016
Table Global Transdermal Scopolamine Sales Volume (Units) and Market Share by Application (2012-2017)
Table Global Transdermal Scopolamine Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Transdermal Scopolamine by Application (2012-2017)
Figure Global Transdermal Scopolamine Sales Market Share by Application (2012-2017)
Figure United States Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure United States Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table United States Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table United States Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure United States Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table United States Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table United States Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure United States Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table United States Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table United States Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure United States Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Figure China Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure China Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table China Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table China Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure China Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table China Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table China Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure China Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table China Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table China Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure China Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Figure Europe Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure Europe Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table Europe Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table Europe Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure Europe Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table Europe Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table Europe Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure Europe Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table Europe Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table Europe Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure Europe Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Figure Japan Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure Japan Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table Japan Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table Japan Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure Japan Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table Japan Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table Japan Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure Japan Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table Japan Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table Japan Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure Japan Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure Southeast Asia Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table Southeast Asia Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table Southeast Asia Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table Southeast Asia Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Figure India Transdermal Scopolamine Sales (Units) and Growth Rate (2012-2017)
Figure India Transdermal Scopolamine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Transdermal Scopolamine Sales Price (K USD/Unit) Trend (2012-2017)
Table India Transdermal Scopolamine Sales Volume (Units) by Players (2012-2017)
Table India Transdermal Scopolamine Sales Volume Market Share by Players (2012-2017)
Figure India Transdermal Scopolamine Sales Volume Market Share by Players in 2016
Table India Transdermal Scopolamine Sales Volume (Units) by Type (2012-2017)
Table India Transdermal Scopolamine Sales Volume Market Share by Type (2012-2017)
Figure India Transdermal Scopolamine Sales Volume Market Share by Type in 2016
Table India Transdermal Scopolamine Sales Volume (Units) by Application (2012-2017)
Table India Transdermal Scopolamine Sales Volume Market Share by Application (2012-2017)
Figure India Transdermal Scopolamine Sales Volume Market Share by Application in 2016
Table Baxter International Inc. Basic Information List
Table Baxter International Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Baxter International Inc. Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure Baxter International Inc. Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure GlaxoSmithKline plc Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Novartis AG Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure Novartis AG Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table Perrigo Company plc. Basic Information List
Table Perrigo Company plc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Perrigo Company plc. Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure Perrigo Company plc. Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table Caleb Pharmaceuticals, Inc. Basic Information List
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table Myungmoon Pharma Co. LTD. Basic Information List
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales Growth Rate (2012-2017)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Sales Global Market Share (2012-2017
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Scopolamine
Figure Manufacturing Process Analysis of Transdermal Scopolamine
Figure Transdermal Scopolamine Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Scopolamine Major Players in 2016
Table Major Buyers of Transdermal Scopolamine
Table Distributors/Traders List
Figure Global Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Global Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Transdermal Scopolamine Price (K USD/Unit) and Trend Forecast (2017-2022)
Table Global Transdermal Scopolamine Sales Volume (Units) Forecast by Regions (2017-2022)
Figure Global Transdermal Scopolamine Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Transdermal Scopolamine Sales Volume Market Share Forecast by Regions in 2022
Table Global Transdermal Scopolamine Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Transdermal Scopolamine Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Transdermal Scopolamine Revenue Market Share Forecast by Regions in 2022
Figure United States Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure China Transdermal Scopolamine Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Europe Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Transdermal Scopolamine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure India Transdermal Scopolamine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Transdermal Scopolamine Sales (Units) Forecast by Type (2017-2022)
Figure Global Transdermal Scopolamine Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Transdermal Scopolamine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Transdermal Scopolamine Revenue Market Share Forecast by Type (2017-2022)
Table Global Transdermal Scopolamine Price (K USD/Unit) Forecast by Type (2017-2022)
Table Global Transdermal Scopolamine Sales (Units) Forecast by Application (2017-2022)
Figure Global Transdermal Scopolamine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

経皮スコポラミン

★調査レポート[世界の経皮スコポラミン市場:販売動向2018] (コード:QYR8021843)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経皮スコポラミン市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆